Diabetic
macular edema is a significant cause of vision loss and an associated complication
of diabetic retinopathy. Lucentis® eye injections work to treat diabetic
macular edema, or swelling of the macula-this leading cause of vision loss
associated with diabetes. Lucentis® has been used for some time to is to treat
“Wet” age-related macular degeneration (AMD). Lucentis® is the first drug FDA
approved to treat diabetic macular edema. More than 500,000 people in the U.S.
have diabetic eye disease and before Lucentis® had to have laser treatment to
address this complication of diabetic retinopathy.
“The use
of Lucentis® to treat diabetic macular edema gives us a great tool and a
significant advantage is managing vision loss from diabetes,” commented Ophthalmologist
Scott Buck, M.D. of Northwest Indiana Eye & Laser Center in Valparaiso, IN.
“As we well know the key to
preservation of eye health and vision for diabetics is early detection,
diagnosis and treatment.”
If you
or someone you know has questions or needs an eye exam for diabetic eye disease
or the problems from diabetic retinopathy and diabetic retinopathy please
feel free to call Northwest Indiana Eye & Laser
Center at 219-464-8223,
or visit Northwest Indiana
Eye & Laser Center
or facebook.com/nwindianaeyeandlaser.
Northwest Indiana Eye & Laser
Center offices are located at 522 Marquette Street, Valparaiso, Indiana 46383
and 1001 South Edgewood Drive, Knox, Indiana 46354.
No comments:
Post a Comment